
A mutation-agnostic gene therapy approach offers new possibilities for patients, especially those with inherited retinal diseases
Allen C. Ho, MD, FACS, FASRS, is director of retina research, Mid Atlantic Retina, Wills Eye Hospital, and professor of ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.